Institutional Sign In

Go

GlaxoSmithKline Czech Republic - Total Assets

GlaxoSmithKline CR`s Total Assets reached 1,520 CZK mil in 2017. This is 0.266 % less than in the previous year.

$1.99

Buy Total Assets data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             227 259 218 267 276    
Bayer Czech Republic CZK mil ... ... ...                 774 572 698 682 830    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 3,166 2,418 2,374 2,019 2,107    
Merck Czech Republic CZK mil ... ...                   445 500 544 476 530    
Novartis Czech Republic CZK mil                       1,401 1,514 1,507 1,646 1,911    
Pfizer Czech Republic CZK mil ... ...                   2,885 2,530 2,812 2,922 1,937    
Roche Czech Republic CZK mil ... ... ...                 2,238 2,344 2,245 2,317 2,548   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               3,167 3,297 2,694 2,348 2,635    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 95.4 110 251 284    
Walmark CZK mil ... ... ...                 1,719 1,596 1,964 2,096 1,607